MDxHealth SA (MDXH.BR) Stock Price & Overview
EBR:MDXH • BE0974461940
Current stock price
The current stock price of MDXH.BR is 3.02 EUR. Today MDXH.BR is down by -3.76%. In the past month the price increased by 5.19%. In the past year, price increased by 381.66%.
MDXH.BR Key Statistics
- Market Cap
- 82.41M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.68
- Dividend Yield
- N/A
MDXH.BR Stock Performance
MDXH.BR Stock Chart
MDXH.BR Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to MDXH.BR. When comparing the yearly performance of all stocks, MDXH.BR is one of the better performing stocks in the market, outperforming 99.77% of all stocks.
MDXH.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MDXH.BR. Both the profitability and financial health of MDXH.BR have multiple concerns.
MDXH.BR Earnings
MDXH.BR Forecast & Estimates
9 analysts have analysed MDXH.BR and the average price target is 8.4 EUR. This implies a price increase of 178.05% is expected in the next year compared to the current price of 3.02.
For the next year, analysts expect an EPS growth of -6519.8% and a revenue growth 84.81% for MDXH.BR
MDXH.BR Groups
Sector & Classification
MDXH.BR Financial Highlights
Over the last trailing twelve months MDXH.BR reported a non-GAAP Earnings per Share(EPS) of -1.68. The EPS decreased by -16.81% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -51.61% | ||
| ROE | -393.48% | ||
| Debt/Equity | 2.17 |
MDXH.BR Ownership
MDXH.BR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARGX | ARGENX SE | 26.92 | 39.964B | ||
| 1AE | ARGENX SE | 26.84 | 39.927B | ||
| 22UA | BIONTECH SE-ADR | N/A | 18.671B | ||
| ABVX | ABIVAX SA | N/A | 8.065B | ||
| 2X1 | ABIVAX SA | N/A | 8.05B | ||
| GLPG | GALAPAGOS NV | N/A | 1.709B | ||
| GXE | GALAPAGOS NV | N/A | 1.707B | ||
| NANO | NANOBIOTIX | N/A | 1.401B | ||
| 6IV | INVENTIVA SA | N/A | 1.001B | ||
| IVA | INVENTIVA SA | N/A | 949.989M | ||
| PHIL | PHILOGEN SPA | 17.73 | 660.824M | ||
| GNFT | GENFIT | 837.75 | 431.525M | ||
| FYB | FORMYCON AG | N/A | 335.023M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Brussels Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About MDXH.BR
Company Profile
MDxHealth SA is a BE-based company operating in Biotechnology industry. The company is headquartered in Herstal, Liege and currently employs 258 full-time employees. The company went IPO on 2006-06-26. MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The firm's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
Company Info
IPO: 2006-06-26
MDxHealth SA
CAP Business Center, Rue d'Abhooz 31
Herstal LIEGE BE
Employees: 258
Phone: 3243642070
MDxHealth SA / MDXH.BR FAQ
Can you describe the business of MDxHealth SA?
MDxHealth SA is a BE-based company operating in Biotechnology industry. The company is headquartered in Herstal, Liege and currently employs 258 full-time employees. The company went IPO on 2006-06-26. MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The firm's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
What is the stock price of MDxHealth SA today?
The current stock price of MDXH.BR is 3.02 EUR. The price decreased by -3.76% in the last trading session.
Does MDXH stock pay dividends?
MDXH.BR does not pay a dividend.
How is the ChartMill rating for MDxHealth SA?
MDXH.BR has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the analyst forecast for MDXH.BR stock?
9 analysts have analysed MDXH.BR and the average price target is 8.4 EUR. This implies a price increase of 178.05% is expected in the next year compared to the current price of 3.02.
Can you provide the sector and industry classification for MDxHealth SA?
MDxHealth SA (MDXH.BR) operates in the Health Care sector and the Biotechnology industry.
What is MDxHealth SA worth?
MDxHealth SA (MDXH.BR) has a market capitalization of 82.41M EUR. This makes MDXH.BR a Micro Cap stock.